Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Karyopharm Therapeutics Inc Share Price

KPTI

NSQ

$8.58

-$0.36

(-4.03%)

Industry: Biotechnology Sector: Health Care

Karyopharm Therapeutics Inc Analyst Forecast

Overview Returns Financials Ratios News FAQs

Karyopharm Therapeutics Inc Share Price Chart

Karyopharm Therapeutics Inc Key Stock Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$163.69M

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

2.24M

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

0.22

52-week Range info-icon

This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$3.51 L

$10.38 H

$8.58

About Karyopharm Therapeutics Inc, Common Stock

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases in the United States. The company discovers, develops, and commercializes novel and small molecule Selective Inhibitor of Nuclear Export (SINE) compounds that inhibit the nuclear export protein exportin 1 (XPO1). Its lead compound, include XPOVIO in combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma; in combination with dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma; and for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). It also developing Selinexor for treating hematological and solid tumor malignancies, including multiple myeloma, endometrial cancer, myelofibrosis, and DLBCL; and ELTANEXOR for treating Myelodysplastic Neoplasms, as well as verdinexor, KPT-9274, and IL-12 compounds. In addition, the company has license agreement with Menarini Group to develop and commercialize selinexor for human oncology indications; license agreement with Antengene Therapeutics Limited to develop and commercialize selinexor, eltanexor, and KPT-9274 for the treatment and/or prevention of human oncology indications, as well as verdinexor for the diagnosis, treatment, and/or prevention of human non-oncology indications; and distribution agreement for the commercialization of XPOVIO with FORUS Therapeutics Inc. Further, the company has a collaboration with Bristol Myers Squibb company to evaluate novel cereblon E3 ligase modulator agent mezigdomide in combination with Selinexor in patients with relapsed/refractory multiple myeloma. Karyopharm Therapeutics Inc. was incorporated in 2008 and is headquartered in Newton, Massachusetts. more

Industry: BiotechnologySector: Health Care

Karyopharm Therapeutics Inc Stock Returns

Time Frame	KPTI	Sector	S&P500
1-Week Return	37.06%	-1.08%	-1.38%
1-Month Return	8.47%	-0.47%	-1.81%
3-Month Return	56%	2.13%	1.38%
6-Month Return	92.81%	17.04%	5.68%
1-Year Return	-6.18%	6.56%	11.74%
3-Year Return	-82.77%	16.78%	65.15%
5-Year Return	-96.2%	34.34%	73.68%
10-Year Return	-90.19%	137.88%	260.03%

Time Frame	KPTI	Sector	S&P500
1-Week Return	1,376,944,617.90%	-43.23%	-51.55%
1-Month Return	168.91%	-5.57%	-19.93%
3-Month Return	507.05%	8.92%	5.72%
6-Month Return	278.60%	37.58%	11.85%
1-Year Return	-6.18%	6.56%	11.74%
3-Year Return	-44.35%	5.31%	18.20%
5-Year Return	-48.01%	6.08%	11.67%
10-Year Return	-20.72%	9.05%	13.67%

Karyopharm Therapeutics Inc Financials

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	108.08M	209.82M	157.07M	146.03M	145.24M	[{"date":"2020-12-31","value":51.51,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":74.86,"profit":true},{"date":"2023-12-31","value":69.6,"profit":true},{"date":"2024-12-31","value":69.22,"profit":true}]
Cost of Revenue	2.71M	3.40M	5.21M	4.94M	6.01M	[{"date":"2020-12-31","value":45.03,"profit":true},{"date":"2021-12-31","value":56.63,"profit":true},{"date":"2022-12-31","value":86.78,"profit":true},{"date":"2023-12-31","value":82.27,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit	105.38M	206.42M	151.86M	141.09M	139.23M	[{"date":"2020-12-31","value":51.05,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":73.57,"profit":true},{"date":"2023-12-31","value":68.35,"profit":true},{"date":"2024-12-31","value":67.45,"profit":true}]
Gross Margin	97.50%	98.38%	96.68%	96.62%	95.86%	[{"date":"2020-12-31","value":99.1,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":98.27,"profit":true},{"date":"2023-12-31","value":98.21,"profit":true},{"date":"2024-12-31","value":97.44,"profit":true}]

Operating Expenses	277.23M	304.69M	294.06M	270.63M	258.67M	[{"date":"2020-12-31","value":90.99,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":96.51,"profit":true},{"date":"2023-12-31","value":88.82,"profit":true},{"date":"2024-12-31","value":84.9,"profit":true}]
Operating Income	(171.85M)	(98.27M)	(142.20M)	(129.54M)	(119.44M)	[{"date":"2020-12-31","value":-17185000000,"profit":false},{"date":"2021-12-31","value":-9827100000,"profit":false},{"date":"2022-12-31","value":-14220200000,"profit":false},{"date":"2023-12-31","value":-12954000000,"profit":false},{"date":"2024-12-31","value":-11944300000,"profit":false}]
Total Non-Operating Income/Expense	(48.43M)	(51.01M)	(45.36M)	(26.98M)	13.06M	[{"date":"2020-12-31","value":-370.97,"profit":false},{"date":"2021-12-31","value":-390.72,"profit":false},{"date":"2022-12-31","value":-347.4,"profit":false},{"date":"2023-12-31","value":-206.64,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income	(195.96M)	(123.82M)	(164.92M)	(142.78M)	(76.36M)	[{"date":"2020-12-31","value":-19596400000,"profit":false},{"date":"2021-12-31","value":-12382000000,"profit":false},{"date":"2022-12-31","value":-16492200000,"profit":false},{"date":"2023-12-31","value":-14277600000,"profit":false},{"date":"2024-12-31","value":-7636500000,"profit":false}]
Income Taxes	309.00K	268.00K	369.00K	323.00K	57.00K	[{"date":"2020-12-31","value":83.74,"profit":true},{"date":"2021-12-31","value":72.63,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":87.53,"profit":true},{"date":"2024-12-31","value":15.45,"profit":true}]
Income After Taxes	(196.27M)	(124.09M)	(165.29M)	(143.10M)	(76.42M)	[{"date":"2020-12-31","value":-19627300000,"profit":false},{"date":"2021-12-31","value":-12408800000,"profit":false},{"date":"2022-12-31","value":-16529100000,"profit":false},{"date":"2023-12-31","value":-14309900000,"profit":false},{"date":"2024-12-31","value":-7642200000,"profit":false}]

Income From Continuous Operations	(196.27M)	(124.09M)	(165.29M)	(139.77M)	(76.42M)	[{"date":"2020-12-31","value":-19627300000,"profit":false},{"date":"2021-12-31","value":-12408800000,"profit":false},{"date":"2022-12-31","value":-16529100000,"profit":false},{"date":"2023-12-31","value":-13976800000,"profit":false},{"date":"2024-12-31","value":-7642200000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	(196.27M)	(124.09M)	(165.29M)	(143.10M)	(76.42M)	[{"date":"2020-12-31","value":-19627300000,"profit":false},{"date":"2021-12-31","value":-12408800000,"profit":false},{"date":"2022-12-31","value":-16529100000,"profit":false},{"date":"2023-12-31","value":-14309900000,"profit":false},{"date":"2024-12-31","value":-7642200000,"profit":false}]

EPS (Diluted)	(2.73)	(1.71)	(2.03)	(1.25)	(7.67)	[{"date":"2020-12-31","value":-273,"profit":false},{"date":"2021-12-31","value":-171,"profit":false},{"date":"2022-12-31","value":-203,"profit":false},{"date":"2023-12-31","value":-125,"profit":false},{"date":"2024-12-31","value":-767,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	-	94.12%	(25.14%)	(7.03%)	(0.55%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-26.71,"profit":false},{"date":"2023-12-31","value":-7.47,"profit":false},{"date":"2024-12-31","value":-0.58,"profit":false}]
Cost of Revenue	-	25.77%	53.23%	(5.20%)	21.55%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":48.4,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-9.77,"profit":false},{"date":"2024-12-31","value":40.48,"profit":true}]
Gross Profit	-	95.88%	(26.43%)	(7.09%)	(1.32%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-27.57,"profit":false},{"date":"2023-12-31","value":-7.4,"profit":false},{"date":"2024-12-31","value":-1.38,"profit":false}]
Gross Margin	-	0.90%	(1.73%)	(0.07%)	(0.78%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-190.89,"profit":false},{"date":"2023-12-31","value":-7.48,"profit":false},{"date":"2024-12-31","value":-86.09,"profit":false}]

Operating Expenses	-	9.90%	(3.49%)	(7.97%)	(4.42%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-35.21,"profit":false},{"date":"2023-12-31","value":-80.45,"profit":false},{"date":"2024-12-31","value":-44.61,"profit":false}]
Operating Income	-	(42.82%)	44.70%	(8.90%)	(7.79%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-95.78,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-19.92,"profit":false},{"date":"2024-12-31","value":-17.44,"profit":false}]
Total Non-Operating Income/Expense	-	5.32%	(11.09%)	(40.52%)	(148.39%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-208.22,"profit":false},{"date":"2023-12-31","value":-760.94,"profit":false},{"date":"2024-12-31","value":-2786.85,"profit":false}]
Pre-Tax Income	-	(36.81%)	33.19%	(13.43%)	(46.51%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-110.91,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-40.45,"profit":false},{"date":"2024-12-31","value":-140.12,"profit":false}]
Income Taxes	-	(13.27%)	37.69%	(12.47%)	(82.35%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-35.21,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-33.08,"profit":false},{"date":"2024-12-31","value":-218.52,"profit":false}]
Income After Taxes	-	(36.78%)	33.20%	(13.43%)	(46.60%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-110.76,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-40.43,"profit":false},{"date":"2024-12-31","value":-140.33,"profit":false}]

Income From Continuous Operations	-	(36.78%)	33.20%	(15.44%)	(45.32%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-110.76,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-46.5,"profit":false},{"date":"2024-12-31","value":-136.49,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	-	(36.78%)	33.20%	(13.43%)	(46.60%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-110.76,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-40.43,"profit":false},{"date":"2024-12-31","value":-140.33,"profit":false}]

EPS (Diluted)	-	(37.36%)	18.71%	(38.42%)	513.60%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-7.27,"profit":false},{"date":"2022-12-31","value":3.64,"profit":true},{"date":"2023-12-31","value":-7.48,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	38.78M	30.54M	30.02M	37.93M	44.04M	[{"date":"2024-09-30","value":88.06,"profit":true},{"date":"2024-12-31","value":69.34,"profit":true},{"date":"2025-03-31","value":68.15,"profit":true},{"date":"2025-06-30","value":86.12,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Cost of Revenue	1.30M	1.33M	1.30M	1.05M	2.11M	[{"date":"2024-09-30","value":61.52,"profit":true},{"date":"2024-12-31","value":62.99,"profit":true},{"date":"2025-03-31","value":61.57,"profit":true},{"date":"2025-06-30","value":49.74,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Gross Profit	37.48M	29.21M	28.71M	36.88M	41.93M	[{"date":"2024-09-30","value":89.39,"profit":true},{"date":"2024-12-31","value":69.66,"profit":true},{"date":"2025-03-31","value":68.48,"profit":true},{"date":"2025-06-30","value":87.95,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Gross Margin	96.65%	95.64%	95.67%	97.23%	95.20%	[{"date":"2024-09-30","value":99.4,"profit":true},{"date":"2024-12-31","value":98.37,"profit":true},{"date":"2025-03-31","value":98.39,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":97.92,"profit":true}]

Operating Expenses	63.77M	60.49M	61.97M	61.27M	57.15M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":94.87,"profit":true},{"date":"2025-03-31","value":97.18,"profit":true},{"date":"2025-06-30","value":96.08,"profit":true},{"date":"2025-09-30","value":89.63,"profit":true}]
Operating Income	(26.28M)	(31.28M)	(33.26M)	(24.39M)	(15.22M)	[{"date":"2024-09-30","value":-2628300000,"profit":false},{"date":"2024-12-31","value":-3128100000,"profit":false},{"date":"2025-03-31","value":-3325600000,"profit":false},{"date":"2025-06-30","value":-2438700000,"profit":false},{"date":"2025-09-30","value":-1522000000,"profit":false}]
Total Non-Operating Income/Expense	(15.31M)	(9.33M)	(164.00K)	(23.44M)	(28.33M)	[{"date":"2024-09-30","value":-1531400000,"profit":false},{"date":"2024-12-31","value":-933000000,"profit":false},{"date":"2025-03-31","value":-16400000,"profit":false},{"date":"2025-06-30","value":-2344000000,"profit":false},{"date":"2025-09-30","value":-2832800000,"profit":false}]
Pre-Tax Income	(32.04M)	(30.89M)	(23.43M)	(37.21M)	(33.09M)	[{"date":"2024-09-30","value":-3204400000,"profit":false},{"date":"2024-12-31","value":-3088900000,"profit":false},{"date":"2025-03-31","value":-2342600000,"profit":false},{"date":"2025-06-30","value":-3721200000,"profit":false},{"date":"2025-09-30","value":-3309300000,"profit":false}]
Income Taxes	28.00K	(109.00K)	36.00K	40.00K	34.00K	[{"date":"2024-09-30","value":70,"profit":true},{"date":"2024-12-31","value":-272.5,"profit":false},{"date":"2025-03-31","value":90,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":85,"profit":true}]
Income After Taxes	(32.07M)	(30.78M)	(23.46M)	(37.25M)	(33.13M)	[{"date":"2024-09-30","value":-3207200000,"profit":false},{"date":"2024-12-31","value":-3078000000,"profit":false},{"date":"2025-03-31","value":-2346200000,"profit":false},{"date":"2025-06-30","value":-3725200000,"profit":false},{"date":"2025-09-30","value":-3312700000,"profit":false}]

Income From Continuous Operations	(32.07M)	(30.78M)	(23.46M)	(37.25M)	(33.13M)	[{"date":"2024-09-30","value":-3207200000,"profit":false},{"date":"2024-12-31","value":-3078000000,"profit":false},{"date":"2025-03-31","value":-2346200000,"profit":false},{"date":"2025-06-30","value":-3725200000,"profit":false},{"date":"2025-09-30","value":-3312700000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	(32.07M)	(30.78M)	(23.46M)	(37.25M)	(33.13M)	[{"date":"2024-09-30","value":-3207200000,"profit":false},{"date":"2024-12-31","value":-3078000000,"profit":false},{"date":"2025-03-31","value":-2346200000,"profit":false},{"date":"2025-06-30","value":-3725200000,"profit":false},{"date":"2025-09-30","value":-3312700000,"profit":false}]

EPS (Diluted)	(3.90)	(3.60)	(2.77)	(4.07)	(3.82)	[{"date":"2024-09-30","value":-390,"profit":false},{"date":"2024-12-31","value":-360,"profit":false},{"date":"2025-03-31","value":-277,"profit":false},{"date":"2025-06-30","value":-407,"profit":false},{"date":"2025-09-30","value":-382,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	-	(21.25%)	(1.73%)	26.37%	16.12%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-80.59,"profit":false},{"date":"2025-03-31","value":-6.54,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":61.15,"profit":true}]
Cost of Revenue	-	2.38%	(2.25%)	(19.22%)	101.05%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":2.36,"profit":true},{"date":"2025-03-31","value":-2.23,"profit":false},{"date":"2025-06-30","value":-19.02,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Gross Profit	-	(22.07%)	(1.70%)	28.43%	13.70%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-77.62,"profit":false},{"date":"2025-03-31","value":-5.98,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":48.19,"profit":true}]
Gross Margin	-	(1.04%)	0.02%	1.63%	(2.08%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-63.68,"profit":false},{"date":"2025-03-31","value":1.5,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-127.53,"profit":false}]

Operating Expenses	-	(5.13%)	2.44%	(1.14%)	(6.72%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-210.14,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-46.56,"profit":false},{"date":"2025-09-30","value":-274.84,"profit":false}]
Operating Income	-	19.02%	6.31%	(26.67%)	(37.59%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":33.2,"profit":true},{"date":"2025-06-30","value":-140.24,"profit":false},{"date":"2025-09-30","value":-197.67,"profit":false}]
Total Non-Operating Income/Expense	-	(39.08%)	(98.24%)	14192.68%	20.85%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-0.28,"profit":false},{"date":"2025-03-31","value":-0.69,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":0.15,"profit":true}]
Pre-Tax Income	-	(3.60%)	(24.16%)	58.85%	(11.07%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-6.12,"profit":false},{"date":"2025-03-31","value":-41.06,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-18.81,"profit":false}]
Income Taxes	-	(489.29%)	(133.03%)	11.11%	(15.00%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-4403.57,"profit":false},{"date":"2025-03-31","value":-1197.25,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-135,"profit":false}]
Income After Taxes	-	(4.03%)	(23.78%)	58.78%	(11.07%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-6.85,"profit":false},{"date":"2025-03-31","value":-40.45,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-18.84,"profit":false}]

Income From Continuous Operations	-	(4.03%)	(23.78%)	58.78%	(11.07%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-6.85,"profit":false},{"date":"2025-03-31","value":-40.45,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-18.84,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	-	(4.03%)	(23.78%)	58.78%	(11.07%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-6.85,"profit":false},{"date":"2025-03-31","value":-40.45,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-18.84,"profit":false}]

EPS (Diluted)	-	(7.69%)	(23.06%)	46.93%	(6.14%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-16.39,"profit":false},{"date":"2025-03-31","value":-49.13,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-13.09,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	289.54M	275.61M	350.16M	233.92M	156.49M	[{"date":"2020-12-31","value":82.69,"profit":true},{"date":"2021-12-31","value":78.71,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":66.8,"profit":true},{"date":"2024-12-31","value":44.69,"profit":true}]
Non-current Assets	23.51M	29.70M	8.01M	6.52M	7.93M	[{"date":"2020-12-31","value":79.16,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":26.97,"profit":true},{"date":"2023-12-31","value":21.94,"profit":true},{"date":"2024-12-31","value":26.69,"profit":true}]
Total Assets	313.05M	305.31M	358.17M	240.44M	164.42M	[{"date":"2020-12-31","value":87.4,"profit":true},{"date":"2021-12-31","value":85.24,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":67.13,"profit":true},{"date":"2024-12-31","value":45.9,"profit":true}]

Total Liabilities
Current Liabilities	297.00K	73.72M	65.91M	69.48M	92.26M	[{"date":"2020-12-31","value":0.32,"profit":true},{"date":"2021-12-31","value":79.9,"profit":true},{"date":"2022-12-31","value":71.43,"profit":true},{"date":"2023-12-31","value":75.3,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Liabilities	262.21M	311.26M	308.92M	307.17M	258.17M	[{"date":"2020-12-31","value":84.24,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":99.25,"profit":true},{"date":"2023-12-31","value":98.68,"profit":true},{"date":"2024-12-31","value":82.94,"profit":true}]
Total Liabilities	262.50M	384.98M	374.83M	376.64M	350.44M	[{"date":"2020-12-31","value":68.19,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":97.36,"profit":true},{"date":"2023-12-31","value":97.84,"profit":true},{"date":"2024-12-31","value":91.03,"profit":true}]

Total Shareholders' equity
Common Stock	7.00K	8.00K	12.00K	12.00K	13.00K	[{"date":"2020-12-31","value":53.85,"profit":true},{"date":"2021-12-31","value":61.54,"profit":true},{"date":"2022-12-31","value":92.31,"profit":true},{"date":"2023-12-31","value":92.31,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Retained Earnings	(1.07B)	(1.18B)	(1.34B)	(1.49B)	(1.56B)	[{"date":"2020-12-31","value":-106961100000,"profit":false},{"date":"2021-12-31","value":-117864800000,"profit":false},{"date":"2022-12-31","value":-134393900000,"profit":false},{"date":"2023-12-31","value":-148703800000,"profit":false},{"date":"2024-12-31","value":-156346000000,"profit":false}]
Other Stockholders' Equity	1.12B	1.10B	1.33B	1.35B	1.38B	[{"date":"2020-12-31","value":81.26,"profit":true},{"date":"2021-12-31","value":79.75,"profit":true},{"date":"2022-12-31","value":96.38,"profit":true},{"date":"2023-12-31","value":98.05,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Shareholders' equity	50.55M	(79.67M)	(16.66M)	(136.21M)	(186.02M)	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-157.62,"profit":false},{"date":"2022-12-31","value":-32.95,"profit":false},{"date":"2023-12-31","value":-269.47,"profit":false},{"date":"2024-12-31","value":-368.02,"profit":false}]

Total Liabilities & Shareholders Equity	313.05M	305.31M	358.17M	240.44M	164.42M	[{"date":"2020-12-31","value":87.4,"profit":true},{"date":"2021-12-31","value":85.24,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":67.13,"profit":true},{"date":"2024-12-31","value":45.9,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	-	(4.81%)	27.05%	(33.20%)	(33.10%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-17.79,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-122.71,"profit":false},{"date":"2024-12-31","value":-122.36,"profit":false}]
Non-current Assets	-	26.32%	(73.03%)	(18.64%)	21.62%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-277.47,"profit":false},{"date":"2023-12-31","value":-70.82,"profit":false},{"date":"2024-12-31","value":82.15,"profit":true}]
Total Assets	-	(2.47%)	17.32%	(32.87%)	(31.62%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-14.29,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-189.83,"profit":false},{"date":"2024-12-31","value":-182.59,"profit":false}]

Total Liabilities
Current Liabilities	-	24720.88%	(10.59%)	5.42%	32.79%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-0.04,"profit":false},{"date":"2023-12-31","value":0.02,"profit":true},{"date":"2024-12-31","value":0.13,"profit":true}]
Non-current Liabilities	-	18.71%	(0.75%)	(0.57%)	(15.95%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-4.02,"profit":false},{"date":"2023-12-31","value":-3.04,"profit":false},{"date":"2024-12-31","value":-85.26,"profit":false}]
Total Liabilities	-	46.66%	(2.64%)	0.48%	(6.96%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-5.65,"profit":false},{"date":"2023-12-31","value":1.04,"profit":true},{"date":"2024-12-31","value":-14.91,"profit":false}]

Total Shareholders' equity
Common Stock	-	14.29%	50.00%	-	8.33%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":28.57,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":16.67,"profit":true}]
Retained Earnings	-	10.19%	14.02%	10.65%	5.14%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":72.69,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":75.93,"profit":true},{"date":"2024-12-31","value":36.65,"profit":true}]
Other Stockholders' Equity	-	(1.86%)	20.85%	1.74%	1.98%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-8.93,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":8.33,"profit":true},{"date":"2024-12-31","value":9.51,"profit":true}]
Total Shareholders' equity	-	(257.62%)	(79.09%)	717.76%	36.57%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-35.89,"profit":false},{"date":"2022-12-31","value":-11.02,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":5.1,"profit":true}]

Total Liabilities & Shareholders Equity	-	(2.47%)	17.32%	(32.87%)	(31.62%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-14.29,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-189.83,"profit":false},{"date":"2024-12-31","value":-182.59,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	184.75M	156.49M	120.24M	97.87M	89.75M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":84.7,"profit":true},{"date":"2025-03-31","value":65.08,"profit":true},{"date":"2025-06-30","value":52.97,"profit":true},{"date":"2025-09-30","value":48.58,"profit":true}]
Non-current Assets	4.72M	7.93M	7.47M	7.01M	6.49M	[{"date":"2024-09-30","value":59.56,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":94.28,"profit":true},{"date":"2025-06-30","value":88.43,"profit":true},{"date":"2025-09-30","value":81.83,"profit":true}]
Total Assets	189.48M	164.42M	127.71M	104.88M	96.23M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":86.78,"profit":true},{"date":"2025-03-31","value":67.4,"profit":true},{"date":"2025-06-30","value":55.35,"profit":true},{"date":"2025-09-30","value":50.79,"profit":true}]

Total Liabilities
Current Liabilities	61.49M	92.26M	90.37M	99.22M	87.16M	[{"date":"2024-09-30","value":61.98,"profit":true},{"date":"2024-12-31","value":92.99,"profit":true},{"date":"2025-03-31","value":91.08,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":87.85,"profit":true}]
Non-current Liabilities	287.63M	258.17M	243.22M	244.59M	278.33M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":89.76,"profit":true},{"date":"2025-03-31","value":84.56,"profit":true},{"date":"2025-06-30","value":85.04,"profit":true},{"date":"2025-09-30","value":96.77,"profit":true}]
Total Liabilities	349.12M	350.44M	333.60M	343.81M	365.49M	[{"date":"2024-09-30","value":95.52,"profit":true},{"date":"2024-12-31","value":95.88,"profit":true},{"date":"2025-03-31","value":91.27,"profit":true},{"date":"2025-06-30","value":94.07,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	13.00K	13.00K	13.00K	13.00K	13.00K	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Retained Earnings	(1.53B)	(1.56B)	(1.59B)	(1.62B)	(1.66B)	[{"date":"2024-09-30","value":-153268000000,"profit":false},{"date":"2024-12-31","value":-156346000000,"profit":false},{"date":"2025-03-31","value":-158692200000,"profit":false},{"date":"2025-06-30","value":-162417400000,"profit":false},{"date":"2025-09-30","value":-165730100000,"profit":false}]
Other Stockholders' Equity	1.37B	1.38B	1.38B	1.39B	1.39B	[{"date":"2024-09-30","value":98.92,"profit":true},{"date":"2024-12-31","value":99.24,"profit":true},{"date":"2025-03-31","value":99.5,"profit":true},{"date":"2025-06-30","value":99.8,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Shareholders' equity	(159.65M)	(186.02M)	(205.88M)	(238.93M)	(269.26M)	[{"date":"2024-09-30","value":-15964700000,"profit":false},{"date":"2024-12-31","value":-18601700000,"profit":false},{"date":"2025-03-31","value":-20588400000,"profit":false},{"date":"2025-06-30","value":-23892600000,"profit":false},{"date":"2025-09-30","value":-26925800000,"profit":false}]

Total Liabilities & Shareholders Equity	189.48M	164.42M	127.71M	104.88M	96.23M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":86.78,"profit":true},{"date":"2025-03-31","value":67.4,"profit":true},{"date":"2025-06-30","value":55.35,"profit":true},{"date":"2025-09-30","value":50.79,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	-	(15.30%)	(23.17%)	(18.60%)	(8.30%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]
Non-current Assets	-	67.89%	(5.72%)	(6.21%)	(7.46%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-8.42,"profit":false},{"date":"2025-06-30","value":-9.15,"profit":false},{"date":"2025-09-30","value":-10.99,"profit":false}]
Total Assets	-	(13.22%)	(22.33%)	(17.88%)	(8.24%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

Total Liabilities
Current Liabilities	-	50.04%	(2.05%)	9.79%	(12.15%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-4.1,"profit":false},{"date":"2025-06-30","value":19.56,"profit":true},{"date":"2025-09-30","value":-24.29,"profit":false}]
Non-current Liabilities	-	(10.24%)	(5.79%)	0.56%	13.80%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-74.24,"profit":false},{"date":"2025-03-31","value":-41.96,"profit":false},{"date":"2025-06-30","value":4.06,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Liabilities	-	0.38%	(4.81%)	3.06%	6.31%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":5.96,"profit":true},{"date":"2025-03-31","value":-76.19,"profit":false},{"date":"2025-06-30","value":48.52,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Retained Earnings	-	2.01%	1.50%	2.35%	2.04%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":85.55,"profit":true},{"date":"2025-03-31","value":63.93,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":86.89,"profit":true}]
Other Stockholders' Equity	-	0.33%	0.26%	0.30%	0.20%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":78.09,"profit":true},{"date":"2025-06-30","value":90.57,"profit":true},{"date":"2025-09-30","value":61.14,"profit":true}]
Total Shareholders' equity	-	16.52%	10.68%	16.05%	12.70%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":64.66,"profit":true},{"date":"2025-06-30","value":97.16,"profit":true},{"date":"2025-09-30","value":76.86,"profit":true}]

Total Liabilities & Shareholders Equity	-	(13.22%)	(22.33%)	(17.88%)	(8.24%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	(160.23M)	(107.12M)	(149.55M)	(92.72M)	(127.49M)	[{"date":"2020-12-31","value":-16023400000,"profit":false},{"date":"2021-12-31","value":-10711600000,"profit":false},{"date":"2022-12-31","value":-14955400000,"profit":false},{"date":"2023-12-31","value":-9272300000,"profit":false},{"date":"2024-12-31","value":-12748600000,"profit":false}]

Investing Activities
Net Investing Cash Flow	(53.69M)	141.84M	(104.26M)	7.94M	95.47M	[{"date":"2020-12-31","value":-37.85,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-73.5,"profit":false},{"date":"2023-12-31","value":5.6,"profit":true},{"date":"2024-12-31","value":67.31,"profit":true}]

Financing Activities
Net Financing Cash Flow	172.08M	73.65M	193.74M	1.12M	41.65M	[{"date":"2020-12-31","value":88.82,"profit":true},{"date":"2021-12-31","value":38.01,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":0.58,"profit":true},{"date":"2024-12-31","value":21.5,"profit":true}]

Net Change in Cash	(41.57M)	108.32M	(60.56M)	(83.69M)	9.62M	[{"date":"2020-12-31","value":-38.37,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-55.91,"profit":false},{"date":"2023-12-31","value":-77.26,"profit":false},{"date":"2024-12-31","value":8.88,"profit":true}]

Free Cash Flow
Free Cash Flow	(160.38M)	(112.83M)	(149.67M)	(92.72M)	(127.63M)	[{"date":"2020-12-31","value":-16037900000,"profit":false},{"date":"2021-12-31","value":-11282800000,"profit":false},{"date":"2022-12-31","value":-14967200000,"profit":false},{"date":"2023-12-31","value":-9272300000,"profit":false},{"date":"2024-12-31","value":-12762800000,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	-	(33.15%)	39.62%	(38.00%)	37.49%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-83.67,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-95.92,"profit":false},{"date":"2024-12-31","value":94.63,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	(364.21%)	(173.50%)	(107.62%)	1102.43%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-33.04,"profit":false},{"date":"2022-12-31","value":-15.74,"profit":false},{"date":"2023-12-31","value":-9.76,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Financing Activities
Net Financing Cash Flow	-	(57.20%)	163.06%	(99.42%)	3605.16%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-1.59,"profit":false},{"date":"2022-12-31","value":4.52,"profit":true},{"date":"2023-12-31","value":-2.76,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Net Change in Cash	-	(360.59%)	(155.91%)	38.20%	(111.50%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-944,"profit":false},{"date":"2022-12-31","value":-408.15,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-291.89,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(29.65%)	32.66%	(38.05%)	37.64%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-78.76,"profit":false},{"date":"2022-12-31","value":86.75,"profit":true},{"date":"2023-12-31","value":-101.08,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	(19.45M)	(25.81M)	(38.98M)	(18.70M)	(5.86M)	[{"date":"2024-09-30","value":-1945300000,"profit":false},{"date":"2024-12-31","value":-2581000000,"profit":false},{"date":"2025-03-31","value":-3898400000,"profit":false},{"date":"2025-06-30","value":-1869700000,"profit":false},{"date":"2025-09-30","value":-586000000,"profit":false}]

Investing Activities
Net Investing Cash Flow	7.47M	14.80M	15.29M	18.29M	4.80M	[{"date":"2024-09-30","value":40.88,"profit":true},{"date":"2024-12-31","value":80.92,"profit":true},{"date":"2025-03-31","value":83.61,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":26.28,"profit":true}]

Financing Activities
Net Financing Cash Flow	-	680.00K	-	356.00K	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":52.35,"profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Net Change in Cash	(11.94M)	(10.35M)	(23.69M)	(48.00K)	(39.08M)	[{"date":"2024-09-30","value":-1194300000,"profit":false},{"date":"2024-12-31","value":-1035300000,"profit":false},{"date":"2025-03-31","value":-2369100000,"profit":false},{"date":"2025-06-30","value":-4800000,"profit":false},{"date":"2025-09-30","value":-3907500000,"profit":false}]

Free Cash Flow
Free Cash Flow	(19.45M)	(25.86M)	(38.98M)	(18.70M)	(5.86M)	[{"date":"2024-09-30","value":-1945300000,"profit":false},{"date":"2024-12-31","value":-2586300000,"profit":false},{"date":"2025-03-31","value":-3898400000,"profit":false},{"date":"2025-06-30","value":-1869700000,"profit":false},{"date":"2025-09-30","value":-586000000,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	-	32.68%	51.04%	(52.04%)	(68.66%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":64.02,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-101.95,"profit":false},{"date":"2025-09-30","value":-134.51,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	97.98%	3.32%	19.60%	(73.72%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":3.39,"profit":true},{"date":"2025-06-30","value":20.01,"profit":true},{"date":"2025-09-30","value":-75.24,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Net Change in Cash	-	(13.31%)	128.83%	(99.80%)	81306.25%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-0.02,"profit":false},{"date":"2025-03-31","value":0.16,"profit":true},{"date":"2025-06-30","value":-0.12,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	-	32.95%	50.73%	(52.04%)	(68.66%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":64.95,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-102.58,"profit":false},{"date":"2025-09-30","value":-135.33,"profit":false}]

Karyopharm Therapeutics Inc Ratios

Karyopharm Therapeutics Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

	KPTI
Cash Ratio	0.53
Current Ratio	1.03
Quick Ratio	0.98

Karyopharm Therapeutics Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	KPTI
ROA (LTM)	-45.56%
ROE (LTM)	-891.05%

Karyopharm Therapeutics Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	KPTI
Debt Ratio Lower is generally better. Negative is bad.	3.80
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	-2.80

Karyopharm Therapeutics Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	KPTI
Trailing PE	NM
Forward PE	NM
P/S (TTM)	1.15
P/B	12.05
Price/FCF	NM
EV/R	2.00
EV/Ebitda	NM
PEG	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Karyopharm Therapeutics Inc share price today?

Karyopharm Therapeutics Inc (KPTI) share price today is $8.58

Can Indians buy Karyopharm Therapeutics Inc shares?

Yes, Indians can buy shares of Karyopharm Therapeutics Inc (KPTI) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in KPTI stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Karyopharm Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Karyopharm Therapeutics Inc (KPTI) via the Vested app. You can start investing in Karyopharm Therapeutics Inc (KPTI) with a minimum investment of $1.

How to invest in Karyopharm Therapeutics Inc shares from India?

You can invest in shares of Karyopharm Therapeutics Inc (KPTI) via Vested in three simple steps:

Click on Sign Up or Invest in KPTI stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Karyopharm Therapeutics Inc shares

What is Karyopharm Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Karyopharm Therapeutics Inc (KPTI) is $10.38. The 52-week low price of Karyopharm Therapeutics Inc (KPTI) is $3.51.

What is Karyopharm Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Karyopharm Therapeutics Inc (KPTI) is

What is Karyopharm Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Karyopharm Therapeutics Inc (KPTI) is 12.05

What is Karyopharm Therapeutics Inc dividend yield?

The dividend yield of Karyopharm Therapeutics Inc (KPTI) is 0.00%

What is the Market Cap of Karyopharm Therapeutics Inc?

The market capitalization of Karyopharm Therapeutics Inc (KPTI) is $163.69M

What is Karyopharm Therapeutics Inc's stock symbol?

The stock symbol (or ticker) of Karyopharm Therapeutics Inc is KPTI

How Can Investors Use Karyopharm Therapeutics Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Karyopharm Therapeutics Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Karyopharm Therapeutics Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Karyopharm Therapeutics Inc shares for Indian investors?

When investing in Karyopharm Therapeutics Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Karyopharm Therapeutics Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Karyopharm Therapeutics Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Karyopharm Therapeutics Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Karyopharm Therapeutics Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Karyopharm Therapeutics Inc Share Price

Karyopharm Therapeutics Inc Analyst Forecast

Karyopharm Therapeutics Inc Share Price Chart

Karyopharm Therapeutics Inc Key Stock Metrics

About Karyopharm Therapeutics Inc, Common Stock

Karyopharm Therapeutics Inc Stock Returns

Karyopharm Therapeutics Inc Financials

Karyopharm Therapeutics Inc Ratios

Karyopharm Therapeutics Inc Liquidity Ratios

Karyopharm Therapeutics Inc Asset Efficiency Ratios

Karyopharm Therapeutics Inc Liability Ratios

Karyopharm Therapeutics Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Company

Explore Products

Popular US Stocks ¹

Popular US ETFs ²

Curated Portfolios (Vests)

Risk Disclosure - US Markets

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Karyopharm Therapeutics Inc Share Price

Karyopharm Therapeutics Inc Analyst Forecast

Karyopharm Therapeutics Inc Share Price Chart

Karyopharm Therapeutics Inc Key Stock Metrics

About Karyopharm Therapeutics Inc, Common Stock

Karyopharm Therapeutics Inc Stock Returns

Karyopharm Therapeutics Inc Financials

Karyopharm Therapeutics Inc Ratios

Karyopharm Therapeutics Inc Liquidity Ratios

Karyopharm Therapeutics Inc Asset Efficiency Ratios

Karyopharm Therapeutics Inc Liability Ratios

Karyopharm Therapeutics Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

Popular US Stocks ¹

Popular US ETFs ²